Audrey Vallée

832 total citations
28 papers, 490 citations indexed

About

Audrey Vallée is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Audrey Vallée has authored 28 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cancer Research, 15 papers in Oncology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Audrey Vallée's work include Cancer Genomics and Diagnostics (19 papers), Lung Cancer Treatments and Mutations (12 papers) and Colorectal Cancer Treatments and Studies (5 papers). Audrey Vallée is often cited by papers focused on Cancer Genomics and Diagnostics (19 papers), Lung Cancer Treatments and Mutations (12 papers) and Colorectal Cancer Treatments and Studies (5 papers). Audrey Vallée collaborates with scholars based in France, Italy and Morocco. Audrey Vallée's co-authors include Marc G. Denis, Sandrine Théoleyre, Guillaume Herbreteau, Amir Khammari, G. Quéreux, Brigitte Dréno, Anne‐Chantal Knol, Émilie Varey, Sandrine Charpentier and Paul Hofman and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Blood.

In The Last Decade

Audrey Vallée

28 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Audrey Vallée France 14 260 235 226 213 49 28 490
Leila Dardaei United States 10 160 0.6× 283 1.2× 349 1.5× 333 1.6× 54 1.1× 13 627
Betül T. Yesilyurt Belgium 8 140 0.5× 194 0.8× 89 0.4× 184 0.9× 71 1.4× 9 452
Barbara Huegli Switzerland 4 229 0.9× 180 0.8× 155 0.7× 203 1.0× 85 1.7× 4 421
Nicola Grehan United Kingdom 8 135 0.5× 138 0.6× 163 0.7× 358 1.7× 285 5.8× 10 719
Brock L. Schweitzer United States 13 177 0.7× 305 1.3× 116 0.5× 155 0.7× 62 1.3× 27 538
Ignacio Wistuba United States 9 72 0.3× 195 0.8× 147 0.7× 183 0.9× 31 0.6× 20 424
Karen Petersen Germany 9 194 0.7× 245 1.0× 251 1.1× 453 2.1× 37 0.8× 9 660
Crispinita D. Arroyo United States 12 220 0.8× 375 1.6× 75 0.3× 224 1.1× 107 2.2× 12 663
Kristina Levan Sweden 14 150 0.6× 106 0.5× 54 0.2× 223 1.0× 55 1.1× 17 463
Jung-Ah Hwang South Korea 15 128 0.5× 152 0.6× 140 0.6× 279 1.3× 27 0.6× 23 447

Countries citing papers authored by Audrey Vallée

Since Specialization
Citations

This map shows the geographic impact of Audrey Vallée's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Audrey Vallée with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Audrey Vallée more than expected).

Fields of papers citing papers by Audrey Vallée

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Audrey Vallée. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Audrey Vallée. The network helps show where Audrey Vallée may publish in the future.

Co-authorship network of co-authors of Audrey Vallée

This figure shows the co-authorship network connecting the top 25 collaborators of Audrey Vallée. A scholar is included among the top collaborators of Audrey Vallée based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Audrey Vallée. Audrey Vallée is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Denis, Marc G., Christine Sagan, Audrey Vallée, et al.. (2023). 1359P Relationship between tumor TP53 gene mutation, circulating anti-p53 antibodies and response to first-line osimertinib in EGFR-mutated NSCLC patients. Annals of Oncology. 34. S781–S781. 1 indexed citations
2.
Herbreteau, Guillaume, Fabrice Airaud, Audrey Vallée, et al.. (2021). MEM: An Algorithm for the Reliable Detection of Microsatellite Instability (MSI) on a Small NGS Panel in Colorectal Cancer. Cancers. 13(16). 4203–4203. 5 indexed citations
3.
Herbreteau, Guillaume, Sandrine Charpentier, Audrey Vallée, & Marc G. Denis. (2019). Use of Circulating Tumoral DNA to Guide Treatment for Metastatic Melanoma. Pharmacogenomics. 20(18). 1259–1270. 4 indexed citations
4.
Herbreteau, Guillaume, Audrey Vallée, Sandrine Charpentier, et al.. (2019). Circulating free tumor DNA in non-small cell lung cancer (NSCLC): clinical application and future perspectives. Journal of Thoracic Disease. 11(S1). S113–S126. 45 indexed citations
5.
6.
Herbreteau, Guillaume, Audrey Vallée, Anne‐Chantal Knol, et al.. (2017). Circulating tumour DNA: analytical aspects and clinical applications for metastatic melanoma patients. Annales de biologie clinique. 75(6). 619–630. 10 indexed citations
7.
Quéreux, G., Guillaume Herbreteau, Anne‐Chantal Knol, et al.. (2017). Efficient treatment of a metastatic melanoma patient with a combination of BRAF and MEK inhibitors based on circulating tumor DNA analysis: a case report. BMC Research Notes. 10(1). 320–320. 7 indexed citations
8.
Denis, M., Audrey Vallée, Sandrine Charpentier, et al.. (2017). Nationwide external quality assessment (EQA) of EGFR testing in circulating tumor DNA: The French experience. Annals of Oncology. 28. v32–v32. 1 indexed citations
9.
Decraene, Charles, Amanda Bortolini Silveira, François‐Clément Bidard, et al.. (2017). Multiple Hotspot Mutations Scanning by Single Droplet Digital PCR. Clinical Chemistry. 64(2). 317–328. 43 indexed citations
10.
Denis, Marc G., Patrick Masson, Audrey Vallée, Thierry Pigeanne, & H. Lacroix. (2015). EGFR Mutation Detection in Plasma of Lung Tumor Patients in the Absence of Contributive Tissue is a Relevant Alternative for Prescription of Tyrosine Kinase Inhibitors in a Routine Clinical Setting. Annals of Oncology. 26. i29–i29. 1 indexed citations
11.
Vallée, Audrey, Guillaume Robert, Christine Le Roy, et al.. (2015). CD9, a key actor in the dissemination of lymphoblastic leukemia, modulating CXCR4-mediated migration via RAC1 signaling. Blood. 126(15). 1802–1812. 42 indexed citations
12.
Denis, Marc G., Audrey Vallée, & Sandrine Théoleyre. (2015). EGFR T790M resistance mutation in non small-cell lung carcinoma. Clinica Chimica Acta. 444. 81–85. 62 indexed citations
13.
14.
Denis, Marc G., Amir Khammari, Audrey Vallée, et al.. (2014). Detection of BRAF mutations in the plasma of melanoma patients as an early marker of treatment efficiency.. Journal of Clinical Oncology. 32(15_suppl). 9069–9069. 1 indexed citations
15.
Saint‐Jean, M., G. Quéreux, Jean‐Michel Nguyen, et al.. (2014). Younger age at the time of first metastasis in BRAF-mutated compared to BRAF wild-type melanoma patients. Oncology Reports. 32(2). 808–814. 6 indexed citations
16.
Vallée, Audrey, et al.. (2013). Detection of EGFR gene mutations in non-small cell lung cancer: Lessons from a single-institution routine analysis of 1,403 tumor samples. International Journal of Oncology. 43(4). 1045–1051. 27 indexed citations
17.
Vallée, Audrey, et al.. (2013). Efficiency of the Therascreen® RGQ PCR kit for the detection of EGFR mutations in non-small cell lung carcinomas. Clinica Chimica Acta. 429. 8–11. 46 indexed citations
18.
Méreau, Agnès, Vincent Anquetil, Marie Cibois, et al.. (2009). Analysis of splicing patterns by pyrosequencing. Nucleic Acids Research. 37(19). e126–e126. 9 indexed citations
19.
Cibois, Marie, Carole Gautier‐Courteille, Audrey Vallée, & Luc Paillard. (2009). A strategy to analyze the phenotypic consequences of inhibiting the association of an RNA-binding protein with a specific RNA. RNA. 16(1). 10–15. 18 indexed citations
20.
Gandemer, Virginie, Marc Aubry, Mikaël Roussel, et al.. (2009). CD9 expression can be used to predict childhood TEL/AML1-positive acute lymphoblastic leukemia: Proposal for an accelerated diagnostic flowchart. Leukemia Research. 34(4). 430–437. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leila Dardaei Breakdown of academic impact, for papers by Betül T. Yesilyurt Breakdown of academic impact, for papers by Barbara Huegli Breakdown of academic impact, for papers by Nicola Grehan Breakdown of academic impact, for papers by Brock L. Schweitzer Breakdown of academic impact, for papers by Ignacio Wistuba Breakdown of academic impact, for papers by Karen Petersen Breakdown of academic impact, for papers by Crispinita D. Arroyo Breakdown of academic impact, for papers by Kristina Levan Breakdown of academic impact, for papers by Jung-Ah Hwang
Rankless by CCL
2026